Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Olmesartan on Potassium Metabolism in Chronic Kidney Disease
2008-002191-98Phase 4Completed
- Sponsor
- Vall d'Hebron University Hospital
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of olmesartan and enalapril in chronic kidney disease (CKD), nephrosclerosis, Microalbuminuria and 1 more (2 arms), sponsored by Vall d'Hebron University Hospital. Primary endpoints: Plasma potassium level, Serum creatinine and 1 more. Started Oct 2008; status: completed.
02
Drugs
olmesartanenalapril
03
Conditions
chronic kidney disease (CKD)nephrosclerosisMicroalbuminuriaessential hypertension
Beyond the preview
Go deeper on 2008-002191-98.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002191-98.